Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00004802Phase 3Completed
A Phase 3 trial of dichlorphenamide in hyperkalemic periodic paralysis (HyperKPP), paramyotonia congenita (PMC), hypokalemic periodic paralysis (HypoPP), sponsored by National Center for Research Resources. Started Jun 1992; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00004802.